Importance of Self-care Behaviors in Diabetes Management
Improving Diabetes Management and Care—Is it All About the Advancement of Pharmacotherapy?
Improving Glycaemic Control - A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Glycaemic Control – A Mandatory Action Calling for Effective Therapeutic Management
Improving Point-of-care Testing with Automated Identification Technologies
Improving Point-of-care Testing with Automated Identification Technologies
Improving Point-of-care Testing with Automated Identification Technologies
Improving Quality of Life in Patients with Pituitary Tumours
In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring
In Pursuit of an Ideal – A Perspective on Non-Invasive Continuous Glucose Monitoring
In Search of Biomarkers—Opportunities in Primary Ovarian Insufficiency
In Search of Biomarkers—Opportunities in Primary Ovarian Insufficiency
Incidence of Hypoglycaemia in Patients with Type 2 Diabetes – A Subgroup Analysis from the GINGER study
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
Incretin Mimetics and Dipeptidyl Peptidase-4 Inhibitors in the Treatment of Type 2 Diabetes
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin Mimetics in the Treatment of Type 2 Diabetes Mellitus
Incretin-based Therapies for Type 2 Diabetes—Comparisons Between Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Incretin-based Therapy and the Prevention of Hypoglycaemia
Inflammation in Pediatric Patients with Type 1 Diabetes—An Early Predictor of Complications?
Inflammation, Oxidative Stress, and the Metabolic Syndrome
Inhaled Human Insulin (EXUBERA®)
Inhaled Human Insulin (Exubera®): An Opportunity for Improving Long-Term Glycaemic Control in Patients with Diabetes?
Inhaled Insulin in Clinical Practice A Focus on Pulmonary Safety
Inhaled Insulin Its Incorporation into the Diabetes Treatment Regimen
Inhaled InsulinA New Development in Glycemic Control for Patients with Diabete
Inhaled InsulinA New Insulin Delivery System
Initiation and Adjustment of Therapy in Type 2 Diabetes
Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment
Initiation of Insulin Treatment in Type 2 Diabetes Mellitus
Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II
Insulin Initiation in Patients not Adequately Controlled on Oral Agents
Insulin Resistance, the Metabolic Syndrome and Renal Failure Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Insulin Resistance, the Metabolic Syndrome and Renal Failure – Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Insulin Resistance, the Metabolic Syndrome and Renal Failure – Is There a Special Problem for Patients Treated with Peritoneal Dialysis?
Intensive Treatment of Type-1 Diabetes The Balance of Benefits and Risks in the DCCT/EDIC Study
International Diabetes Federation - The Global Voice for Diabetes
International Diabetes Federation – The Global Voice for Diabetes
International Diabetes Federation –Putting Women and Diabetes on the Global Agenda
International Diabetes Federation— Putting Women and Diabetes on the Global Agenda
International Menopause Society — Updated Recommendations on Post-menopausal Hormone Therapy
International Menopause Society — Updated Recommendations on Post-menopausal Hormone Therapy
Introduction of New Recombinant Insulin-like Growth Factor - Current and Future Perspectives
Investigating Inhaled Insulin
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Investigation, Treatment and Monitoring of Late-onset Hypogonadism
Iodine-131 Metaiodobenzylguanidine for the Treatment of Neuroendocrine Tumors
Is A1C the Best Measure of Glycemic Control?
Is A1C the Best Measure of Glycemic Control?
Is Prevention the Solution to the Worldwide Epidemic Explosion of Type 2 Diabetes Mellitus?
Is Prevention the Solution to the Worldwide Epidemic Explosion of Type 2 Diabetes Mellitus?
Islet Cell Function Its Role in the Onset and Progression of Type 2 Diabetes
Islet Cell Function – Its Role in the Onset and Progression of Type 2 Diabetes